Telomerase is a ribonucleoprotein polymerase which contains an integral RNA and synthesizes T TAGGG nucleotide repeats at the ends of chromosomes in vertebrates. Accumulated evidence has indicated that telomerase is stringently repressed in normal human somatic tissues but reactivated in immortal and cancer cells, suggesting that activation of telo-merase may play an important role in carcinogenesis. In order to assess the role of telomerase in the development of thyroid cancer, we measured the telomerase activity in 19 frozen samples obtained from patients with benign and malignant thyroid nodules by employing a recently developed sensitive PCR-based telomerase assay (telomeric repeat ampli-fication protocol: TRAP). Telomerase activity was detected in all the thyroid cancer tissues (9 of 9) and 4 out of 8 benign thyroid nodules showed telomerase a c t i v i t y. Three of thyroid cancers with high telomerase activity had an unfavorable prognosis, whereas six cancers with low telomerase activity were associated with a favorable prognosis. Interestingly, Hashimoto's thyroiditis tissues also showed telomerase activity. These results indicate that telomerase may play a key role during thyroid carcinogenesis. K e y w o r d s : telomerase cancer, thyroid nodules, PCR, H a s h m o t o 's thyroiditis, carcinogenesis
I n t r o d u c t i o n
Human cancers are characterized by malignant transformation and immortalization (Shay et al., 1991) . However, d i fficulty in establishing cell lines from cancer tissue samples has led many investigators to question whether cancer cells in vivo are immortal or not (Stamps et al. , 1992) . It has been shown that telomere DNA shortens at chromosome ends with both in vivo and in vitro d i v i s i o n of human somatic cells unless the termini are extended specifically by telomerase (Harley et al., 1990; Lindsey et al., 1991; Allsopp et al., 1992) .
Telomerase is a ribonucleoprotein, RNA-dependent DNA polymerase and acts as a reverse transcriptaselike enzyme which maintains telomere length by adding telomeric repeat units of T TA G G G to the telomere end (Greider et al., 1985; Yu et al., 1990) . It has been suggested that deregulation of telomerase may participate in cellular immortality and oncogenesis. Cells with indefinite replicative potential such as germline cells and almost all tumor cell lines and cancer tissues express telomerase activity (Counter et al., 1994; Kim et al., 1994; Nilsson e t a l., 1994) , while normal human somatic cells show low or undetectable telomerase activity and progressively lose their telomeric sequences both with senescence i n v i t r o and with normal in vivo aging (Hastie et al., 1990; Vaziri et al., 1994) . Therefore, telomerase activation can be directly involved in cell immortalization and telomere maintenance.
The recently developed sensitive PCR-based telomerase assay (telomeric repeat amplification protocol, TRAP) makes it possible to detect the enzyme in a variety of human tumors and tumor-derived cell lines (Kim et al. , 1994) . With this method, we measured telomerase activity in benign and malignant human thyroid nodules to determine whether malignant progression of thyroid cancer may correlate with expression of telomerase.
Materials and Methods

Detergent extracts from tissues
Benign and malignant thyroid nodules were obtained from each of 19 patients during surgery (Hanyang University KURI Hospital). Each tissue sample consisting of 100 mg of frozen tissue (-70˚C) was washed in ice-cold wash b u ffer [10 mM Hepes-KOH (pH 7.5), 1.5 mM MgCl 2 , 10 mM 
Amplification of telomeric repeat
Telomerase activity was assayed by using the modified TRAP method (Kim et al., 1994) . In brief, 0.1 μg of lyophilizing CX primer (5'-{C C C T TA}3 C C C TA A-3 ) was dropped onto the bottom of a tube and we sealed it with 100 μl of wax (Ampliwax, Perkin-Elmer Cetus Corp., Foster C i t y, CA) to prepare the assay tubes. After the wax was allowed to solidify at room temperature, the tubes were stored at 4˚C. Fifty microliter of TRAP reaction mixture above the wax barrier consisted of 20 mM tris-HCl (pH 8.3), 1.5 mM MgCl 2 , 63 mM KCl, 0.005% Tween-20, 1 mM E G TA, 50 μM deoxynucleoside triphosphates, 0.1 μg of TS primer (5'-A AT C C G T C G A G C A G A G T T-3 ), 2U of Ta q polymerase (Promega, Madison, WI) and 6 μg of protein from each CHAPS cell extract. To control for the presence of Ta q polymerase inhibitors (Wright et al., 1995) , the internal telomerase amplification standard (ITAS) primers were included in each analysis. Given 10 min at 30˚C for telomerase to extend oligonucleotide TS, the assay tubes were transferred to the thermal cycler (Robocycler 40; Stratagene, La Jolla, CA) for 35 rounds at 94˚C for 30 s, 5 0˚C for 30 s, and 72˚C for 45 s. The resulting solution was analyzed by using electrophoresis in 1 t r i s -b o r a t e E D TA (TBE) buffer on 15% polyacrylamide nondenaturing gels. Silver staining method was used for visualizing the PCR products after electrophoresis. For an approximate estimation of telomerase activity, positive extracts were re-examined by serial dilution. Extracts that had been diluted both 10 times and 100 times contained 0.6 μg and 0.06 μg of protein, respectively (Hiyama et al., 1995) .
R e s u l t s
Telomerase activity was detected in all the thyroid cancer tissues (9 of 9) and representative results are shown in Figure 1 . Irrespective of clinical characteristics, all the papillary cancer tissues showed telomerase activity and one follicular cancer and one squamous cell cancer tissue was also positive to telomerase, whereas three adjacent normal tissues did not have any telomerase activity ( Figure  2 ). The expression of telomerase in thyroid cancers was not correlated to age, histologic type, or the presence of lymph node metastasis (Table 1) . However, three tumors of thyroid cancer had high telomerase activity (that is, retained a TRAP signal after a 100-fold dilution of the extract) whose representative results are shown in Figure   Figure 1 . Telomerase activity in thyroid cancer tissues. All the thyroid cancer tissues revealed telomerase activity which appeared as characteristic 6 base pair ladder. Human 293 kidney cells served as a positive control (293). Enzyme assay was performed by using TRAP method (Kim et al., 1994) . Reaction products were electrophoresed on 15% polyacrylamide nondenaturing gels and visualized with silver staining. Arrow indicates the ITAS primers to control for the presence of Taq polymerase inhibitors. (Cady et al., 1988) 3 and six tumors had low telomerase activity. Interestingly, three patients with high telomerase activity were high clinical stage and high risk group by AMES risk analysis performed as described previously (Cady et al., 1988) . In 4 of 6 adenomatous hyperplasia telomerase activity was detected, whereas all the follicular adenoma were negative for telomerase activity (Table 2, Figure 3) . The telomerase activity in benign thyroid nodules was detected in 0.6 μg (10-fold dilution) but not in 0.06 μg (100-fold dilution) of protein (Figure 4 ).
H a s h i m o t o 's thyroiditis tissues also revealed telomerase activity (Figure 3 ) being characterized by 6 base pair ladder pattern. With serial dilution of protein, the signal was only detected in 10-fold dilution (Figure 4) 
D i s c u s s i o n
Telomerase activity has been detected in a wide variety of human tumors and tumor derived cell lines, whereas it was not detected in both normal cells in vitro and normal somatic tissues in vivo (Counter et al., 1994; Kim et al. , 1994) . Our study presented here is a systematic examination of telomerase activity in human benign and malignant thyroid nodules.
Telomerase activity was positive in 9 of 9 human thyroid cancer tissues (100%), being characterized by the 6 base pair ladder pattern which has been seen consistently in human 293 kidney cell line as a positive control, whereas normal tissues did not show any telomerase activity. Such high positive rates were also demonstrated in our previous reports tested with head and neck cancer (89%) (Ahn e t a l., 1995), gastric cancer (89%) (Ahn et al., 1997) , and cervical cancer tissues (89%) (Noh et al., 1996) . These findings suggest that telomerase activation may play a significant role in establishment and progression of cancer, irrespective of the tumor type.
All the six early staged tumors and three advanced staged tumors showed telomerase activity. These results indicate that telomerase activation may be present not only in early but also in late stage of cancers. The incidence of telomerase activity in the thyroid cancer tissues was not correlated to age, tumor size, tumor stage, histologic findings or lymph node metastasis. Thyroid cancers with high telomerase activity by semiquantitative methods were high stage and an unfavorable prognosis, whereas tumors with low telomerase activity were associated with a favorable prognosis, suggesting that there may be diff e r e n t mechanisms regulating telomerase activity in thyroid carcinogenesis. Some of the benign thyroid nodules (4 of 8) did show telomerase activity in three independent experiments. With semiquantitative methods, the telomerase activity found in benign thyroid nodules was lower compared to that of thyroid cancer tissues. However, further studies to determine the mechanism and the biological significance of telomerase activity in benign thyroid nodules should be warranted.
H a s h i m o t o 's thyroiditis tissues also revealed telomerase activity indicating that immune activated lymphocytes infiltrating in Hashimoto's thyroiditis tissues may account for telomerase positivity. Recent reports have shown that normal peripheral blood cells such as granulocytes, T and B lymphocytes, and monocytes have weak telomerase activity and strong telomerase activity was also demonstrated even in normal mature cells of the immune system (Nisslon et al., 1994; Broccoli et al., 1995; Counter et al. , 1995; Brousset et al., 1997) .
In conclusion, the present study demonstrated that telomerase activity is highly positive in human thyroid cancer tissues, irrespective of the tumor size, stage, or histologic findings. These findings indicated that telomerase may be involved in malignant transformation and in progression of thyroid cancers. Further studies are necessary in order to fully understand the biological role of telomerase in thyroid cancinogenesis.
